Loading the player...
Beyond Diabetes, GLP-1 Agonists for the Management of Obesity
Clinical applications of GLP-1 inhibitors are expanding beyond diabetes to address treatment gaps in weight management. This presentation provides the clinical evidence supporting their use so that physicians may make informed decisions for their patients and osteopathic medical students.
At the end of this session, the learner will be able to:
Disclosures: none.
NYSOMS is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. NYSOMS designates this program for a maximum of 0.75 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
All grievances may be directed to NYSOMS Executive Director at nysoms@nysoms.org. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
Dr Goldstein earned her Bachelor Science in Pharmacy from the University of Washington, and her Doctor of Pharmacy from Idaho State University and is Associate Professor of Pharmacology and Coordinator of the Academic Medicine Scholars Methods and Research in Medical Education course at NYITCOM. Prior to joining NYITCOM sixteen years ago, she practiced pharmacy for many years and has experience in retail, long-term care, and hospital pharmacy. Her research is medical education, focusing on the effects of various methodologies on learning. Dr. Goldstein is Chair of the NYIT Biomedical and Health Science Institutional Review Board, member of the NYITCOM Curriculum Committee, and member of the New York Tech Optimizing Student Success initiative, and has won the Faculty Award for Excellence in Teaching five times.
